Basis: Unrounded diluted TTM EPS / FMP quote price × 100. Source: stored company filings and market data; unavailable inputs remain N/A.
The earnings yield is N/A as of 2026-10-06T18:00:41.325Z.
Calculation as of: 2026-10-06T18:00:41.325Z.
Quote observation: 2026-10-06T18:00:15.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: ad057aee5ab633aed0c7ef60ea3d5b85ea99b1ff07310db4f6411376a188a91d
EARNINGS YIELD
N/A
Market Cap
$836.35M
Earnings Yield
N/A
TTM Avg
2.16%
3Y Avg
2.16%
5Y Avg
2.16%
Market Cap
$840.85M
Earnings Yield
N/A
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$844.84M
Earnings Yield
N/A
TTM Avg
0.29%
3Y Avg
0.29%
5Y Avg
0.29%
Market Cap
$849.66M
Earnings Yield
N/A
TTM Avg
3.42%
3Y Avg
14.26%
5Y Avg
9.75%
| NAME | MARKET CAP | EARNINGS YIELD | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Alumis Inc. (ALMS) | $833.76M | N/A | N/A | N/A | N/A |
| Monte Rosa Therapeutics, Inc. (GLUE)vs › | $836.35M | N/A | 2.16% | 2.16% | 2.16% |
| Beta Bionics, Inc. (BBNX)vs › | $839.06M | N/A | N/A | N/A | N/A |
| SpyGlass Pharma, Inc. Common Stock (SGP)vs › | $840.85M | N/A | N/A | N/A | N/A |
| Pacific Biosciences of California, Inc. (PACB)vs › | $844.84M | N/A | 0.29% | 0.29% | 0.29% |
| QuidelOrtho Corporation (QDEL)vs › | $849.66M | N/A | 3.42% | 14.26% | 9.75% |
| SL Science Holding Ltd (SLBT)vs › | $855.16M | N/A | N/A | N/A | N/A |
| Ardelyx, Inc. (ARDX)vs › | $810.26M | N/A | 0.51% | 0.51% | 0.51% |
| SI-BONE, Inc. (SIBN)vs › | $860.28M | N/A | N/A | N/A | N/A |
| Rigel Pharmaceuticals, Inc. (RIGL)vs › | $860.37M | 35.10% | 38.06% | 23.44% | 23.44% |
Earnings Yield
N/A
EPS ÷ Price
P/E Ratio
N/A
Price ÷ EPS
Formula: Earnings Yield = (EPS / Price) × 100
Earnings Yield is simply the inverse of P/E. A P/E of 20 equals a 5% earnings yield.
How earnings yield is used:
Earnings Yield = EPS (TTM) / Share Price
Earnings yield is the inverse of the PE ratio, expressing trailing earnings as a percentage of price. Higher is cheaper.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
